Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06872190
- Status
- Recruiting
Conditions
- Opioid Use Disorder
- Social Determinants of Health (SDOH)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ED-Based Clinical Decision Support for Opioid Use Disorder — OTHERThe original clinical decision support (CDS) tool, EMergency department initiated BuprenorphinE for opioid use Disorder or EMBED, was designed by researchers at Yale to support emergency department (ED) clinicians with varying levels of experience prescribing buprenorphine for patients with opioid use disorder (OUD). The tool alerts ED providers of a patient who is potentially eligible for MOUD using Epic's storyboard. The provider must then click on the notification to open the OUD evaluation tool, which has multiple components: OUD assessment, OUD diagnosis, withdrawal assessment, and readiness for treatment. These components are then paired with an orderset, "ED Opioid Use Disorder Treatment" that includes nursing orders, prescriptions for buprenorphine and ancillary medications, and substance use disorder discharge resources.
- Social Care-Enhanced Clinical Decision Support for Opioid Use Disorder — OTHERThe investigators will use human-centered design to adapt the basic CDS tool to incorporate patient social needs, involving patients, staff, and end-user ED clinicians in the iterative design process. This tool is being actively developed.
Study Details
The overarching goal of this proposal is to integrate patient social risk information into an existing electronic health record (EHR)-based clinical decision support (CDS) tool (CDSv1) to facilitate emergency department (ED)-initiated, social risk-informed opioid use disorder (OUD) medication treatment and ultimately improve treatment adherence and follow up. The investigators will evaluate the feasibility and acceptability of the social care-enhanced CDS tool, CDSv2, (compared to CDSv1) at a single study site (UCSF) as an intervention to increase medication treatment adherence and follow up for adult ED patients experiencing opioid use disorder using a mixed-methods, before-after approach.
Key Dates
- Start date
- Apr 20, 2025
- Status verified
- May 2025
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: ED-Based Clinical Decision Support for Opioid Use DisorderEmergency providers will have access to the basic ED-based clinical decision support tool for opioid use disorder.
- Experimental: Social Care-Enhanced Clinical Decision Support for Opioid Use DisorderEmergency providers will no longer have access to the basic ED-based clinical decision support tool for opioid use disorder, but will instead have access to the social care-enhanced clinical decision support tool for opioid use disorder.
Primary Outcome Measure
CDSv1 clinician launch [ Time Frame: 12 months ]
Central Contacts
- Melanie F Molina, MD, MAS415-353-1156
- Jacob Perez
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | - |
Find similar trials in San Francisco, CA
Related Studies
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.PHASE4 · Recruiting · Yale University · Oakland, California
- An Integrated Intervention Using a Pill Ingestible Sensor SystemPHASE2 · Recruiting · University of California, Los Angeles · Los Angeles, California